Likelihood of most adverse treatment outcomes lowest with active surveillance of clinically localized prostate CA (ProtecT)

Likelihood of most adverse treatment outcomes lowest with active surveillance of clinically localized prostate CA (ProtecT) is a topic covered in the EE+ POEM Archive.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Likelihood of most adverse treatment outcomes lowest with active surveillance of clinically localized prostate CA (ProtecT) ID - 1314139 ED - Barry,Henry, ED - Ebell,Mark H, ED - Shaughnessy,Allen F, ED - Slawson,David C, BT - EE+ POEM Archive UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314139/all/Likelihood_of_most_adverse_treatment_outcomes_lowest_with_active_surveillance_of_clinically_localized_prostate_CA__ProtecT_ PB - John Wiley & Sons DB - Evidence Central DP - Unbound Medicine ER -